SCHEMBL4350030

SCHEMBL4350030

Cc1c(F)c(F)cc(N=C=S)c1F

nearest known ligand 0.31

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.31
LMNA P02545 1/20 0.31
ABCB11 O95342 1/20 0.31
NR3C1 P04150 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
ADRA2A P08913 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
ADRA2C P18825 1/20 0.31
MAOA P21397 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A4 P31645 1/20 0.31
HTR2B P41595 1/20 0.31
CCR2 P41597 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
APLNR P35414 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5017628 0.86 ALDH1A1 (0.30) ALDH1A1LMNA
SCHEMBL1996908 0.79 CYP3A4 (0.47) ALDH1A1CYP3A4HPGDTDP1
SCHEMBL15589318 0.77 ALDH1A1 (0.38) ALDH1A1LMNAABCB11NR3C1CYP1A2
SCHEMBL22602515 0.73 ALDH1A1 (0.30) ALDH1A1LMNA
SCHEMBL1399737 0.73 ABCB11 (0.34) ALDH1A1ABCB11NR3C1CYP1A2CYP3A4
SCHEMBL11362110 0.71 CES2 (0.31)
SCHEMBL169896 0.71 CA1 (0.38)
SCHEMBL13788635 0.71 ALDH1A1 (0.34) ALDH1A1LMNAABCB11NR3C1CYP1A2
SCHEMBL15221620 0.69 ALDH1A1 (0.33) ALDH1A1LMNAABCB11NR3C1CYP1A2
SCHEMBL4350033 0.69 GABRA1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094677-A1 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES NV Remynd (BE) 2009-09-02 EP disclosed
WO-2008061781-A1 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES NV REMYND (BE) 2008-05-29 WO disclosed